| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wood Barbara A |
SVP,General Counsel,Secretary |
• – – |
2018-01-02 |
4 |
S |
$3.19 |
$16,872 |
D/D |
(5,289) |
15,183 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2018-01-02 |
4 |
S |
$3.19 |
$25,804 |
D/D |
(8,089) |
36,495 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2018-01-02 |
4 |
S |
$3.19 |
$52,699 |
D/D |
(16,520) |
33,974 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel,Secretary |
• – – |
2017-12-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,140 |
20,472 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2017-12-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,420 |
44,584 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2017-12-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,480 |
50,494 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel,Secretary |
• – – |
2017-07-05 |
4 |
S |
$2.58 |
$13,207 |
D/D |
(5,119) |
8,332 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2017-07-05 |
4 |
S |
$2.58 |
$20,196 |
D/D |
(7,828) |
24,164 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2017-07-05 |
4 |
S |
$2.58 |
$45,609 |
D/D |
(17,678) |
20,014 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel,Secretary |
• – – |
2017-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,140 |
13,451 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2017-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,420 |
31,992 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2017-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,480 |
37,692 |
|
- |
|
| Redlick David E |
Director |
– • – |
2017-06-13 |
4 |
AS |
$2.52 |
$1,764 |
D/D |
(700) |
1,050 |
|
- |
|
| Ross Michael Jay |
Director |
– • – |
2017-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
3,500 |
|
- |
|
| Redlick David E |
Director |
– • – |
2017-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
|
- |
|
| Sblendorio Glenn |
President, CFO and Treasurer |
• – – |
2017-04-03 |
4 |
S |
$3.56 |
$26,301 |
D/D |
(7,388) |
11,572 |
|
- |
|
| Sblendorio Glenn |
President, CFO and Treasurer |
• – – |
2017-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
18,960 |
|
- |
|
| Westby Keith |
SVP & COOOfficer |
• – – |
2017-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,175 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel,Secretary |
• – – |
2017-01-05 |
4 |
S |
$4.96 |
$2,921 |
D/D |
(589) |
1,311 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2017-01-05 |
4 |
S |
$4.96 |
$19,066 |
D/D |
(3,844) |
15,813 |
|
- |
|
| Bjarke Henric Bjorn |
SVP & CCO |
• – – |
2017-01-05 |
4 |
S |
$4.96 |
$1,567 |
D/D |
(316) |
1,384 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2017-01-05 |
4 |
S |
$4.96 |
$18,774 |
D/D |
(3,785) |
7,212 |
|
- |
|
| Wood Barbara A |
SVP,General Counsel,Secretary |
• – – |
2017-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,200 |
1,900 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2017-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
19,657 |
|
- |
|
| Bjarke Henric Bjorn |
SVP & CCO |
• – – |
2017-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
1,700 |
|
- |
|
468 Records found
|
|
Page 10 of 19 |
|
|
